FORT WASHINGTON, Pa.--(BUSINESS WIRE)--The National Comprehensive Cancer Network® (NCCN®) Affiliate Research Project (ARP), developed by the NCCN Oncology Research Project (ORP), has qualified Norton Cancer Institute, a community-based affiliate of Moffitt Cancer Center—one of the 21 NCCN Member Institutions.
“NCCN is pleased to announce the qualification of Norton Cancer Institute”
Located in Louisville, Kentucky, Norton Cancer Institute is operating as an ARP site under the leadership of John Hamm, MD, Medical Director, Norton Cancer Institute Research Program.
The mission of the NCCN ARP is to improve patient outcomes and advance medical science through clinical research conducted by means of collaboration among 21 NCCN Member Institutions and their community-based affiliate networks.
Norton Cancer Institute is the eighth community-based NCCN Member Institution affiliate to qualify for the NCCN ARP, increasing the scope of potential patients for the more than 60 actively accruing ORP trials. Previously approved NCCN Member Institution affiliates include AtlantiCare Cancer Care Institute, South Jersey Healthcare, and Virtua—affiliates of Fox Chase Cancer Center; Bozeman Deaconess Hospital, MultiCare Health System, and Wenatchee Valley Medical Center—affiliates of Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; and Medical Center of Central Georgia—an affiliate of University of Alabama at Birmingham Comprehensive Cancer Center.
Norton Cancer Institute will have access to new and innovative cancer drugs for patients in collaboration with NCCN Member Institutions; Principal Investigators of NCCN-funded studies will have access to Norton Cancer Institute as an NCCN-qualified community site.
“NCCN is pleased to announce the qualification of Norton Cancer Institute,” said Diane Paul, Vice President of the NCCN ORP. “Indeed, the growth of the NCCN Affiliate Research Project will strengthen the NCCN Oncology Research Program through the expansion of an already diverse patient base and afford a growing opportunity to community patients to participate in best-in-class clinical trials.”
The NCCN ORP is organized to obtain funding to support scientifically meritorious research projects at NCCN Member Institutions. Policies and standards for the program were set by the NCCN Investigator Steering Committee, a group comprised of senior research physicians appointed by each NCCN Member Institution. To date, the NCCN ORP has received nearly $40 million in research grants from pharmaceutical and biotech companies to support investigator-initiated trials including, but not limited to, evaluation of innovative regimens, mechanism of action, and exploration of extended uses for specific agents.
About Norton Cancer Institute
As four-time winner of the prestigious Press Ganey Summit Award for excellence in patient care, Norton Cancer Institute’s mission is to blend comprehensive healing, compassion and hope for patients and their families. Our team of experts is dedicated to offering patients confidence and the latest in care techniques through a multidisciplinary approach to advanced cancer prevention, diagnosis, treatment and survivorship. Norton Cancer Institute offers a broad range of cancer specialists, services and programs, including the da Vinci minimally invasive surgical system; a $1-million Mobile Prevention Center; and cancer radiation centers offering state-of-the-art stereotactic radiosurgery and advanced brachytherapy technologies. Norton Cancer Institute also provides extensive educational, physical, and emotional support services, as well as industry-leading cancer research studies and clinical trials. Norton Cancer Institute is the only integrated Network Program accredited by the American College of Surgeons in Kentucky. In 2010, Norton Cancer Institute was selected to join the National Cancer Institute Community Cancer Centers Program. Norton Cancer Institute is the only NCCCP site in Kentucky and one of just 21 sites in the nation. More information is available at NortonCancerInstitute.com.
About Moffitt Cancer Center
Located in Tampa, FL Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Since 1999, Moffitt has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.
About National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.
The NCCN Member Institutions are: City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas MD Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN.